BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32194689)

  • 1. Prognosis of ovarian clear cell cancer compared with other epithelial cancer types: A population-based analysis.
    Liu H; Xu Y; Ji J; Dong R; Qiu H; Dai X
    Oncol Lett; 2020 Mar; 19(3):1947-1957. PubMed ID: 32194689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear cell carcinomas of the ovary have poorer outcomes compared with serous carcinomas: Results from a single-center Taiwanese study.
    Ku FC; Wu RC; Yang LY; Tang YH; Chang WY; Yang JE; Wang CC; Jung SM; Lin CT; Chang TC; Chao A; Lai CH
    J Formos Med Assoc; 2018 Feb; 117(2):117-125. PubMed ID: 28389144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis.
    Lee YY; Kim TJ; Kim MJ; Kim HJ; Song T; Kim MK; Choi CH; Lee JW; Bae DS; Kim BG
    Gynecol Oncol; 2011 Sep; 122(3):541-7. PubMed ID: 21640372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.
    Han G; Gilks CB; Leung S; Ewanowich CA; Irving JA; Longacre TA; Soslow RA
    Am J Surg Pathol; 2008 Jul; 32(7):955-64. PubMed ID: 18460981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear cell carcinoma of the ovary: a review of the literature.
    del Carmen MG; Birrer M; Schorge JO
    Gynecol Oncol; 2012 Sep; 126(3):481-90. PubMed ID: 22525820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
    Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study.
    Zhou L; Yao L; Dai L; Zhu H; Ye X; Wang S; Cheng H; Ma R; Liu H; Cui H; Chang X
    J Ovarian Res; 2021 May; 14(1):63. PubMed ID: 33941230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry.
    Engqvist H; Parris TZ; Kovács A; Rönnerman EW; Sundfeldt K; Karlsson P; Helou K
    Front Oncol; 2020; 10():162. PubMed ID: 32133296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours.
    Browne A; Sriraksa R; Guney T; Rama N; Van Noorden S; Curry E; Gabra H; Stronach E; El-Bahrawy M
    Cytokine; 2013 Oct; 64(1):413-21. PubMed ID: 23727325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic review.
    Miyamoto M; Takano M; Goto T; Kato M; Sasaki N; Tsuda H; Furuya K
    J Gynecol Oncol; 2013 Jan; 24(1):37-43. PubMed ID: 23346312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trial.
    Timmers PJ; Zwinderman AH; Teodorovic I; Vergote I; Trimbos JB
    Int J Gynecol Cancer; 2009 Jan; 19(1):88-93. PubMed ID: 19258948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.
    Uehara Y; Oda K; Ikeda Y; Koso T; Tsuji S; Yamamoto S; Asada K; Sone K; Kurikawa R; Makii C; Hagiwara O; Tanikawa M; Maeda D; Hasegawa K; Nakagawa S; Wada-Hiraike O; Kawana K; Fukayama M; Fujiwara K; Yano T; Osuga Y; Fujii T; Aburatani H
    PLoS One; 2015; 10(6):e0128066. PubMed ID: 26043110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary.
    Morioka S; Kawaguchi R; Yamada Y; Iwai K; Yoshimoto C; Kobayashi H
    J Ovarian Res; 2019 Feb; 12(1):20. PubMed ID: 30803452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of intranuclear inclusions is useful for the cytological diagnosis of ovarian clear cell carcinoma.
    Naka M; Ohishi Y; Kaku T; Watanabe S; Tamiya S; Ookubo F; Kato K; Oda Y; Sugishima S
    Diagn Cytopathol; 2015 Nov; 43(11):879-84. PubMed ID: 26219930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma.
    Zhang X; Guo G; Wang G; Zhao J; Wang B; Yu X; Ding Y
    Mol Med Rep; 2015 Dec; 12(6):8021-31. PubMed ID: 26497752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma.
    Ju UC; Kang WD; Kim SM
    Int J Gynaecol Obstet; 2019 Aug; 146(2):177-183. PubMed ID: 31081117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of pure and mixed-type clear cell carcinoma of the ovary: a clinicopathological analysis of 341 Chinese patients.
    Ye S; You Y; Yang J; Cao D; Bai H; Huang H; Wu M; Chen J; Lang J; Shen K
    Int J Gynecol Cancer; 2014 Nov; 24(9):1590-6. PubMed ID: 25254564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
    Moss EL; Evans T; Pearmain P; Askew S; Singh K; Chan KK; Ganesan R; Hirschowitz L
    Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
    Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
    Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
    [No Abstract]   [Full Text] [Related]  

  • 20. Apparent diffusion coefficient (ADC) values of serous, endometrioid, and clear cell carcinoma of the ovary: pathological correlation.
    Ono T; Kishimoto K; Tajima S; Maeda I; Takagi M; Suzuki N; Mimura H
    Acta Radiol; 2020 Jul; 61(7):992-1000. PubMed ID: 31698924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.